116 related articles for article (PubMed ID: 1672154)
61. The Thomsen-Friedenreich (T) simple mucin-type carbohydrate antigen in salivary gland carcinomas.
Therkildsen MH; Mandel U; Christensen M; Dabelsteen E
Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):361-7. PubMed ID: 8746265
[TBL] [Abstract][Full Text] [Related]
62. Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation.
Chiu KY; Loke SL; Ho FC
J Clin Pathol; 1994 Feb; 47(2):117-21. PubMed ID: 7907612
[TBL] [Abstract][Full Text] [Related]
63. Immunoexpression of hoxb7 and hoxb9 in salivary gland tumours.
Fonseca FP; Bingle L; Santos-Silva AR; Lopes MA; Coletta RD; de Andrade BA; Mariano FV; Kowalski LP; Rangel AL; Martins MD; Meurer L; Hunter KD; Speight PM; Vargas PA
J Oral Pathol Med; 2016 Oct; 45(9):672-681. PubMed ID: 26991799
[TBL] [Abstract][Full Text] [Related]
64. Methodologic aspects of DNA assessment by means of image cytometry in tumors of the salivary glands. A comparison between the results obtained using sections and cytospin preparations from the same paraffin-embedded specimens.
Schimmelpenning H; Hamper K; Falkmer UG; Caselitz J; Seifert G; Auer GU
Anal Quant Cytol Histol; 1989 Dec; 11(6):379-83. PubMed ID: 2557851
[TBL] [Abstract][Full Text] [Related]
65. Expression of c-erbB-2 oncoprotein in human thyroid tumours.
Utrilla JC; Martín-Lacave I; San Martín MV; Fernández-Santos JM; Galera-Davidson H
Histopathology; 1999 Jan; 34(1):60-5. PubMed ID: 9934586
[TBL] [Abstract][Full Text] [Related]
66. Immunoreactivity of proliferating cell nuclear antigen in salivary gland tumours: an assessment of growth potential.
Yang L; Hashimura K; Qin C; Shrestha P; Sumitomo S; Mori M
Virchows Arch A Pathol Anat Histopathol; 1993; 422(6):481-6. PubMed ID: 8101406
[TBL] [Abstract][Full Text] [Related]
67. Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumour stage, and cell proliferation in malignant salivary gland tumours.
Kamio N
Virchows Arch; 1996 May; 428(2):75-83. PubMed ID: 8925128
[TBL] [Abstract][Full Text] [Related]
68. Identification and characterization of primary cilia-positive salivary gland tumours exhibiting basaloid/myoepithelial differentiation.
Shinmura K; Kusafuka K; Kawasaki H; Kato H; Hariyama T; Tsuchiya K; Kawanishi Y; Funai K; Misawa K; Mineta H; Sugimura H
J Pathol; 2021 Aug; 254(5):519-530. PubMed ID: 33931860
[TBL] [Abstract][Full Text] [Related]
69. Expression of cytokeratins and vimentin in salivary gland carcinomas as revealed with monoclonal antibodies.
Gustafsson H; Virtanen I; Thornell LE
Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):515-24. PubMed ID: 2452508
[TBL] [Abstract][Full Text] [Related]
70. Immunohistochemical characterisation of extracellular matrix components of salivary gland tumours.
Nara Y; Takeuchi J; Yoshida K; Fukatsu T; Nagasaka T; Kawaguchi T; Meng N; Kikuchi H; Nakashima N
Br J Cancer; 1991 Aug; 64(2):307-14. PubMed ID: 1909886
[TBL] [Abstract][Full Text] [Related]
71. Tenascin in salivary gland tumours.
Soini Y; Pääkkö P; Virtanen I; Lehto VP
Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):217-22. PubMed ID: 1384222
[TBL] [Abstract][Full Text] [Related]
72. Expression of the ERBB2 protein in benign and malignant salivary gland tumors.
Stenman G; Sandros J; Nordkvist A; Mark J; Sahlin P
Genes Chromosomes Cancer; 1991 Mar; 3(2):128-35. PubMed ID: 1676907
[TBL] [Abstract][Full Text] [Related]
73. Identification of Metallothionein- and parathyroid hormone-related peptide (PTHrP)-positive cells in salivary gland tumours.
Sunardhi-Widyaputra S; van den Oord JJ; Van Houdt K; De Ley M; Van Damme B
Pathol Res Pract; 1995 Nov; 191(11):1092-8. PubMed ID: 8822110
[TBL] [Abstract][Full Text] [Related]
74. Myoepithelial cells in salivary gland neoplasms.
Gustafsson H; Bergman F; Virtanen I; Thornell LE
APMIS; 1989 Jan; 97(1):49-55. PubMed ID: 2464356
[TBL] [Abstract][Full Text] [Related]
75. Localization of salivary amylase and epithelial membrane antigen in salivary gland tumours by means of immunoperoxidase and immunogold-silver techniques.
Egan M; Crocker J; Nar P
J Laryngol Otol; 1988 Mar; 102(3):242-7. PubMed ID: 2451703
[TBL] [Abstract][Full Text] [Related]
76. Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study.
Suwanagool P; Parichatikanond P; Maeda S
Asian Pac J Allergy Immunol; 1993 Dec; 11(2):119-22. PubMed ID: 7915904
[TBL] [Abstract][Full Text] [Related]
77. Immunohistochemical expression of MAM-3 and MAM-6 antigens in salivary gland tumours.
Yamada K; Tanaka T; Mori M; Tsubura A; Morii S; Tsubone M; Ando C; Hilgers J
Virchows Arch A Pathol Anat Histopathol; 1989; 415(6):509-21. PubMed ID: 2508309
[TBL] [Abstract][Full Text] [Related]
78. Expression of c-erbB-2 protein detected in adenocarcinoma arising from parotid pleomorphic adenoma.
Sugawara K; Mori S; Morita M
Auris Nasus Larynx; 1990; 17(2):115-20. PubMed ID: 1977376
[TBL] [Abstract][Full Text] [Related]
79. Parotid gland tumours in a West Indian population: Comparison to world trends.
Ramdass MJ; Maharaj K; Mooteeram J; Dwarika W; Tilluckdharry C; Barrow S
Mol Clin Oncol; 2015 Jan; 3(1):167-170. PubMed ID: 25469289
[TBL] [Abstract][Full Text] [Related]
80. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW
J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
